Consolidated Balance Sheet

OncoTherapy Science, Inc. - Filing #7736657

Concept As at
2017-06-30
As at
2017-03-31
Consolidated balance sheet
Balance sheet
Assets
Non-current assets
Property, plant and equipment
Buildings, net
165,067,000 JPY
173,366,000 JPY
Property, plant and equipment
206,732,000 JPY
219,804,000 JPY
Intangible assets
14,341,000 JPY
15,926,000 JPY
Software
4,375,000 JPY
4,731,000 JPY
Other
72,000 JPY
72,000 JPY
Intangible assets
Patent right
9,893,000 JPY
11,122,000 JPY
Other intangible assets
Investments and other assets
Investments and other assets
65,932,000 JPY
68,140,000 JPY
Guarantee deposits
64,322,000 JPY
64,320,000 JPY
Long-term prepaid expenses
1,609,000 JPY
3,819,000 JPY
Non-current assets
287,006,000 JPY
303,871,000 JPY
Current assets
Cash and deposits
9,183,354,000 JPY
10,072,962,000 JPY
Accounts receivable - trade
216,353,000 JPY
1,790,000 JPY
Raw materials and supplies
13,243,000 JPY
13,010,000 JPY
Other
135,677,000 JPY
122,025,000 JPY
Advance payments to suppliers
83,244,000 JPY
79,110,000 JPY
Current assets
9,631,872,000 JPY
10,288,900,000 JPY
Assets
9,918,879,000 JPY
10,592,771,000 JPY
Liabilities and net assets
Non-current liabilities
119,398,000 JPY
118,564,000 JPY
Asset retirement obligations
109,241,000 JPY
107,362,000 JPY
Current liabilities
285,209,000 JPY
369,909,000 JPY
Accounts payable - other
267,988,000 JPY
297,567,000 JPY
Liabilities
404,607,000 JPY
488,473,000 JPY
Shareholders' equity
9,139,736,000 JPY
9,707,069,000 JPY
Share capital
9,135,574,000 JPY
9,135,118,000 JPY
Capital surplus
12,100,796,000 JPY
12,100,340,000 JPY
Retained earnings
-12,096,633,000 JPY
-11,528,389,000 JPY
Valuation and translation adjustments
-8,741,000 JPY
-8,235,000 JPY
Foreign currency translation adjustment
-8,741,000 JPY
-8,235,000 JPY
Share acquisition rights
383,275,000 JPY
405,463,000 JPY
Net assets
9,514,271,000 JPY
10,104,297,000 JPY
Liabilities and net assets
9,918,879,000 JPY
10,592,771,000 JPY
Liabilities
Non-current liabilities
Current liabilities
Income taxes payable
1,144,000 JPY
54,724,000 JPY
Other
15,717,000 JPY
17,257,000 JPY
Advances received
359,000 JPY
359,000 JPY
Net assets
Shareholders' equity
Valuation and translation adjustments

Talk to a Data Expert

Have a question? We'll get back to you promptly.